Also, I focus on the three TNF inhibitors, because we ran the analysis Europe's ageing Population: Healthy and Working, or a Burden on Society? Page 4 of 16 26 February 2008 A cne.org transcript over a time series, and the two most recent biologicals in this field only came onto the determines access what causes the differences in who gets the drugs, and how many patients get the drugs? In the stu. [...] The way we have done that, the only data that are available across the world are sales all our estimates on prices from the manufacturer to the wholesale market and the public so this is not the price a patient would pay. [...] These data are absolutely necessary to get a clear picture of the enormous size of the challenge we have to face, which is: how to improve the lives of people affected by rheumatoid arthritis (RA) and how to reduce the huge economic burden on society. [...] You can find it in the Eurobarometer and also in the report of the Bone and Joint Decade, which gave an overview of prevalence and incidence of all musculoskeletal diseases in Europe. [...] In my environment, I have very young colleagues who have arthritis and they are totally out of possibilities, because we The other thing that I would like to say is, I feel a little puzzled with, and I can understand if you go to the Parliament and you go to the Commission and you see all these civil servants from all the t that.
- Pages
- 16
- Published in
- Belgium
